Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5843 record(s)

Req # A-2022-000600

Adverse Drug Reactions (ADRs). Report numbers: E2B_05218423, E2B_05234166, E2B_05293043, E2B_05302793, E2B_05168052, E2B_04998941, E2B_05206136, E2B_05118213, E2B_05239163, E2B_05249285.

Organization: Health Canada

99 page(s)
September 2023

Req # A-2022-001066

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107475-990

Organization: Health Canada

93 page(s)
September 2023

Req # A-2022-001219

Adverse Drug Reaction (ADR). Report number: E2B_05625713.

Organization: Health Canada

10 page(s)
September 2023

Req # A-2022-001240

Adverse Drug Reaction (ADR). Report number: E2B_05020433.

Organization: Health Canada

9 page(s)
September 2023

Req # A-2022-001277

Adverse Drug Reactions (ADRs) for MORPHINE. Report numbers: E2B_05814334, E2B_05840954, E2B_05793140. ADR for NALTREXONE. Report number: 001012975. ADRs for HYDROMORPHONE. Report numbers: 001013828, E2B_05851510.

Organization: Health Canada

118 page(s)
September 2023

Req # A-2022-001448

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075391-48.

Organization: Health Canada

12 page(s)
September 2023

Req # A-2022-001454

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-112856-848.

Organization: Health Canada

7 page(s)
September 2023

Req # A-2022-001500

Adverse Drug Reaction (ADR) for MORPHINE. Report number: 001019927. ADRs for HEPARIN AI. Report numbers: E2B_05991667, E2B_06019838, E2B_06023997.

Organization: Health Canada

109 page(s)
September 2023

Req # A-2022-001520

Adverse Drug Reactions (ADRs) for MESALAZINE. Report numbers: 001022111, 001022820, 001022749, 001023019, 001022984. ADRs for MESALAMINE. Report numbers: E2B_05978116, E2B_05990113, E2B_05960176, E2B_06023958.

Organization: Health Canada

82 page(s)
September 2023

Req # A-2022-001553

Adverse Drug Reactions (ADRs). Report numbers: 001023620, E2B_06033606, E2B_06074495, E2B_06033839, E2B_06041914, E2B_06057050.

Organization: Health Canada

69 page(s)
September 2023
Date modified: